{"product_id":"trajanscimed-five-forces-analysis","title":"Trajan Porter's Five Forces Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eElevate Your Analysis with the Complete Porter's Five Forces Analysis\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eTrajan's Five Forces snapshot highlights supplier leverage, buyer sensitivity, competitive rivalry, substitution risk, and entry barriers shaping its strategic options and margins.\u003c\/p\u003e\n\u003cp\u003eThis brief overview teases how supplier concentration and niche competitors compress pricing power while innovation and regulatory hurdles limit new entrants.\u003c\/p\u003e\n\u003cp\u003eReady for the full picture? Unlock the complete Porter's Five Forces Analysis for force-by-force ratings, visuals, and actionable insights to inform investment or strategy.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euppliers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Raw Material Dependency\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eTrajan depends on medical-grade polymers, specialty glass, and high-purity metals, and only about 8–12 global suppliers meet required ISO 13485 and USP standards, giving suppliers strong pricing power. In 2024 Trajan spent ~£42m on these niche inputs (38% of COGS), so a 10% price rise would cut gross margin by ~3.8 percentage points. Supply disruptions—seen in 2021–22 with lead times jumping 3–6 months—could halt production and force costly qualification of alternates.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVertical Integration Impact\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBy acquiring key suppliers between 2019–2024, Trajan reduced third-party spend by about 38% and internalized roughly 45% of critical component production for its analytical devices as of FY2024, cutting COGS volatility and improving gross margin by ~220 basis points. This vertical integration lets Trajan control quality, shorten lead times (average supplier lead time fell from 18 to 8 days) and lower external suppliers’ bargaining power materially.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eQuality Standards and Regulatory Compliance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSuppliers must meet stringent international quality standards and regulatory requirements (ISO 9001, GMP, EU MDR) to stay in Trajan Porter’s supply chain, creating a high entry barrier that in 2024 left 78% of procurement spend with 12 certified vendors; this concentrates bargaining power among compliant suppliers. Trajan pays a 6–12% premium for certified inputs, so it must balance quality needs with lock-in risk and seek dual sourcing or long-term contracts to reduce cost exposure.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSwitching Costs for Precision Inputs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSwitching suppliers for precision scientific components incurs high costs from re-validation and regulatory recertification; industry estimates put re-validation at $250k–$1.2M and 3–9 months per critical input (2024 supplier audit data).\u003c\/p\u003e\n\u003cp\u003eFor Trajan, changing a key material provider would likely require extensive analytical testing to confirm result integrity, reinforcing incumbent suppliers' leverage given deep workflow integration.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRe-validation cost: $250k–$1.2M (2024)\u003c\/li\u003e\n\u003cli\u003eTime: 3–9 months per input\u003c\/li\u003e\n\u003cli\u003eRaises supplier bargaining power\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Supply Chain Volatility\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpas of late geopolitical tensions and port congestions have pushed lead times for specialized components up year-over-year allowed suppliers in stable high-tech hubs to charge premiums reducing trajan porter margin flexibility.\u003e\n\u003cptrajan must diversify away from single-region dependence supplier concentration at in one geography raises disruption risk and could cost an estimated annual lost revenue under a six-week outage.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLead times +22% YoY\u003c\/li\u003e\n\u003cli\u003eSupplier premiums 8–15%\u003c\/li\u003e\n\u003cli\u003e46% supplier concentration\u003c\/li\u003e\n\u003cli\u003e$12–18m estimated outage loss\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/ptrajan\u003e\u003c\/pas\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupplier concentration risks £42m spend: 10% price hike cuts margin ~3.8pp; 46% geo risk\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSuppliers hold substantial power: 8–12 certified global vendors supply critical inputs, 2024 spend ~£42m (38% COGS); a 10% input price rise cuts gross margin ~3.8pp. Vertical integration (2019–24) internalized 45% production, cutting external spend 38% and improving gross margin ~220bps; lead times fell 18→8 days. Re-validation costs $250k–$1.2M and 3–9 months raise switching costs. Geo concentration 46% risks $12–18m loss under six-week outage.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSupplier pool\u003c\/td\u003e\n\u003ctd\u003e8–12\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProcurement spend\u003c\/td\u003e\n\u003ctd\u003e£42m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCOGS share\u003c\/td\u003e\n\u003ctd\u003e38%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eVerticalized production\u003c\/td\u003e\n\u003ctd\u003e45%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGross margin gain\u003c\/td\u003e\n\u003ctd\u003e+220bps\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRe-validation cost\u003c\/td\u003e\n\u003ctd\u003e$250k–$1.2M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSwitch time\u003c\/td\u003e\n\u003ctd\u003e3–9 months\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGeo concentration\u003c\/td\u003e\n\u003ctd\u003e46%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEstimated outage loss\u003c\/td\u003e\n\u003ctd\u003e$12–18m (6 weeks)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eUncovers Trajan's competitive pressures by analyzing supplier and buyer power, substitutes, new entrant threats, and industry rivalry to highlight risks and strategic opportunities.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCompact five-forces snapshot that highlights competitive pressure points for rapid strategy decisions, with editable scores and a radar chart for immediate visual clarity.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConcentration of Large Scale Laboratories\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eA large share of Trajan’s revenue comes from big pharma and global environmental labs; in 2024 the top 10 clients reportedly accounted for about 42% of sales, giving them leverage to demand steep discounts and bespoke SLAs. These buyers’ high-volume purchasing power and low switching costs let them push price cuts of 10–20% at renewal and shift multi-million-dollar contracts quickly, raising Trajan’s customer-concentration risk.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh Switching Costs in Validated Workflows\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp many of trajan porter consumables are embedded in validated lab workflows subject to fda ema or iso rules re-validating after a brand change can cost labs and months per industry benchmarks so buyers face real friction.\u003e\n\u003c\/p\u003e\n\u003cp this re-validation burden raises customer stickiness reducing effective bargaining power even for large institutional buyers who otherwise drive price pressure.\u003e\n\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDemand for Integrated Life Science Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eModern customers prefer end-to-end life-science solutions over standalone components, and Trajan’s combined hardware-plus-consumables model strengthens retention; bundled buyers report 22–30% lower churn in industry surveys (2024).\u003c\/p\u003e\n\u003cp\u003eTrajan’s ecosystem approach boosts recurring consumable revenue—consumables accounted for ~38% of Trajan Group revenue in FY2024—making pure price-based switching less attractive.\u003c\/p\u003e\n\u003cp\u003eProviding validated hardware-consumable pairs also raises switching costs through workflow disruption and regulatory requalification, so customers shop less on price and more on total-system value.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrice Sensitivity in Routine Testing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eIn food safety and environmental monitoring, routine testing is high-volume, low-margin; buyers typically switch for price rises above 5–10%—a 2024 Eurofins survey found 62% of labs prioritize cost over brand for routine assays.\u003c\/p\u003e\n\u003cp\u003eTrajan’s premium pricing risks substitution by generic consumables unless performance or throughput adds ≥15–20% value; that forces continuous product innovation and cost efficiency to defend margin.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e62% labs choose cost-first (Eurofins, 2024)\u003c\/li\u003e\n\u003cli\u003e5–10% price sensitivity threshold\u003c\/li\u003e\n\u003cli\u003eNeed ≥15–20% performance edge to justify premium\u003c\/li\u003e\n\u003cli\u003eHigh volume → thin margin pressure\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInfluence of Contract Manufacturing Clients\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cptrajan contract-manufacturing clients can be both customers and competitors giving them high bargaining power in trajan reported revenue from third-party pharma contracts concentrating risk margin pressure.\u003e\u003cpthese clients often demand ip safeguards and lower prices surveys show of cmos accept margin compression to retain large pharma accounts trajan must protect proprietary capabilities while meeting strict quality kpis.\u003e\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e40% revenue from contract pharma (2024)\u003c\/li\u003e\n\u003cli\u003e62% of CMOs accept margin pressure\u003c\/li\u003e\n\u003cli\u003eIP clauses common in major contracts\u003c\/li\u003e\n\u003cli\u003eBalance quality KPIs vs. proprietary tech\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pthese\u003e\u003c\/ptrajan\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh buyer concentration vs. switching frictions: Trajan needs 15–20% edge\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eLarge buyers (top 10 ≈42% revenue, 2024) push 10–20% discounts, but regulatory re-validation costs ($50k–$250k, 4–12 months) and bundled hardware+consumables (consumables ≈38% revenue FY2024) raise switching costs, lowering effective bargaining power; routine labs switch at 5–10% price moves, so Trajan must sustain ≥15–20% performance edge to defend premium.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue (2024)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTop-10 customer share\u003c\/td\u003e\n\u003ctd\u003e≈42%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eConsumables share\u003c\/td\u003e\n\u003ctd\u003e≈38% rev\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRe-validation cost\/time\u003c\/td\u003e\n\u003ctd\u003e$50k–$250k \/ 4–12m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrice sensitivity\u003c\/td\u003e\n\u003ctd\u003e5–10%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePremium threshold\u003c\/td\u003e\n\u003ctd\u003e15–20%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Version Awaits\u003c\/span\u003e\u003cbr\u003eTrajan Porter's Five Forces Analysis\u003c\/h2\u003e\n\u003cp\u003eThis preview shows the exact Trajan Porter's Five Forces Analysis you'll receive immediately after purchase—no placeholders or samples; the full, professionally formatted document is ready for download and use the moment you buy.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56747270898041,"sku":"trajanscimed-five-forces-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/trajanscimed-five-forces-analysis.png?v=1772196930","url":"https:\/\/matrixbcg.com\/products\/trajanscimed-five-forces-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}